Hepatitis, Viral, Human

Search with Google Search with Bing
Information
Disease name
Hepatitis, Viral, Human
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00000580 Completed Phase 3 Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin November 1975 June 1986
NCT00000583 Completed Phase 3 Hepatitis B Vaccine Clinical Trial November 1978 June 1980
NCT00005304 Completed Delta Hepatitis and Liver Disease in Hemophiliacs September 1986 September 1991
NCT00005305 Completed Hepatitis Delta Infections in Hemophiliacs September 1987 September 1991
NCT00005306 Completed Natural History of Post-transfusion Non-A, Non-B Hepatitis March 1988 September 2001
NCT00005309 Completed Prospective Study of HIV Infection in Hemophiliacs July 1990 March 1995
NCT00005339 Completed Risk of Post Transfusion Hepatitis C Virus Infection February 1992 April 2004
NCT00007371 Completed Hepatitis C in Clinically Discordant Hemophilic Siblings September 1999 August 2004
NCT00029406 Completed Transfusion Infections Pediatric Prospective Study (TRIPPS) April 2001 April 2013
NCT00097006 Completed Retrovirus Epidemiology Donor Study-II (REDS-II) September 2004 September 2009
NCT00116454 Completed Phase 3 Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis July 2005 August 2013
NCT00230854 Completed Phase 1 Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin August 2005 July 2007
NCT01170741 Completed Phase 1 Computer-Assisted Tailored Cue-card Health [CATCH] Study June 2010 June 2012
NCT01532973 Completed Phase 1 Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) February 16, 2012 May 17, 2013
NCT01804829 Completed Phase 3 Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. June 2013 June 2016
NCT03410953 Completed Phase 4 Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines April 13, 2018 October 31, 2019
NCT00342186 Completed Genes Involved in Resistance or Susceptibility to Hepatitis B Virus September 27, 2002 February 22, 2018
NCT00564811 Completed N/A Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) March 2003 September 2004
NCT00608192 Completed N/A HIV and Hepatitis Care Coordination in Methadone Treatment January 2008 June 2011
NCT00913757 Completed A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area July 1, 2009 May 1, 2020
NCT00915057 Completed Phase 2 Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. March 2009 March 2009
NCT01163240 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B June 2009
NCT05492565 Enrolling by invitation Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis January 1, 2020 December 31, 2030
NCT00318682 Terminated Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis May 2006 August 2008
NCT02613403 Terminated Phase 2 Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) December 10, 2015 March 27, 2017
NCT03776760 Unknown status Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination May 28, 2019 August 2022
MeSH unique ID (MeSH (Medical Subject Headings))
D006525